US 5,856,440 AGranted

Solid phase process for synthesizing thymosin .alpha..sub.1

AssigneeAlpha-1 Biomedicals, Inc.

InventorSu S. Wang

Life of this patent

Estimating the term…

Loading patent…

Abstract

4-methyloxybenzyloxycarbonyl (Moz) is used to protect the alpha amino groups of the amino acids used in solid-phase synthesis of thymosin .alpha..sub.1. It was found that the Moz group can be removed rapidly and completely with 5-10% trifluoroacetic acid in CH.sub.2 Cl.sub.2. Some advantages of utilizing Moz-amino acids over Boc-amino acids in solid-phase peptide synthesis are higher yields and purities with reduced consumption of trifluoroacetic acid during the acidolytic cleavage of the N.sup..alpha. -Moz groups. Further improvements with respect to the recovery and recycling of the used solvent are obtained by using tributylamine in place of triethylamine as the neutralization agent making it possible to distill methylene chloride from the liquid waste without contamination by the lower boiling triethylamine. Methylbenzhydrylamine resin is the preferred resin support. Cleavage from the resin support and deprotection of the protected side groups of the protected thymosin .alpha..sub.1 can be accomplished using either HBr or trifluoromethane sulfonic acid in trifluoroacetic acid with anisole and thioanisole as scavengers.

Claims18

Dependent claims

A process for producing thymosin .alpha..sub.1, or a biologically active analog or fragment thereof by solid-phase peptide synthesis, comprising the steps of (a) temporarily chemically protecting the reactive amino group at the alpha-position, and any other reactive groups, other than beta carboxylic acid group, on the C-terminal amino acid of the thymosin .alpha..sub.1 peptide with 4-methoxybenzyloxycarbonyl;

(b) chemically bonding the protected C-terminal amino acid via the unprotected carboxylic acid (--COOH) group thereof to a resin support;
(c) chemically deprotecting the reactive amino group of the resin-bound protected amino acid by acidolytic cleavage using liquid trifluoroacetic acid;
(d) chemically coupling via a peptide bond the next amino acid in the desired sequence by contacting the resin-bound amino acid from step (c) with the next amino acid in the desired sequence with all of the reactive groups thereof, other than the carboxylic acid group at the alpha-position, chemically protected with 4-methoxybenzyloxycarbonyl, in the presence of a coupling agent;
(e) chemically deprotecting the reactive amino group of the coupled amino acid from step (d) by acidolytic cleavage using liquid trifluoroacetic acid;
(f) continuing the synthesis by repeating steps (d) and (e) with successive amino acids in the desired sequence being added one at a time until the total desired sequence of the protected peptide is built up on the resin;
and (g) cleaving the protected peptide from the resin support and deprotecting protected reaction groups using liquid trifluoroacetic acid,
whereby the volume of liquid trifluoroacetic acid used in steps (c) and (e) is substantially reduced as compared to the volume of liquid trifluoroacetic acid required in steps (c) and (e) when the alpha-amino groups of each successive amino acid are protected with tert-butyloxycarbonyl (BOC).

4 more elements

Dependencies are inferred from the claim text.